Low-dose recombinant interferon therapy in anti-HBe-positive chronic hepatitis B in Asian Indians

Journal of Gastroenterology and Hepatology (Australia)

Volumn 13, Issue 7, 1998, Pages 675-679

  Guptan, Raj Kumar C ^a   Thakur, Varsha ^a   Malhotra, Veena ^a   Sarin, Shiv K ^a  

^a G B PANT HOSPITAL   (India)

Author keywords

Chronic hepatitis B; Cirrhosis; HBV DNA; Interferon; Precore HBV mutant

Indexed keywords

HEPATITIS B(E) ANTIBODY; RECOMBINANT ALPHA2B INTERFERON; SERUM ALBUMIN; VIRUS DNA;

ADULT; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; FATIGUE; FEMALE; FEVER; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; INDIAN; LEUKOPENIA; MALAISE; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA; VIRUS MUTANT;

EID: 0031751246     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1998.tb00712.x     Document Type: Article

References (27)

1. Liaw YF, Pao CC, Chu CM, Sheen IS, Huang MJ. Changes of serum hepatitis B virus DNA in two types of clinical events preceding spontaneous hepatitis Be antigen seroconversion in chronic type B hepatitis. Hepatology 1987; 7: 1-3.
2. Readi G, Alberti A, Rugge M et al. Seroconversion from hepatitis Be antigen to anti HBe in chronic hepatitis B virus infection. Gastroenterology 1980; 79: 195-9.
3. Bonino F, Rosina F, Rizzetto M et al. Chronic hepatitis in HBsAg carriers with serum HBV DNA and antiHBe. Gastroenterology 1986; 90: 1268-73.
4. Brunetto RM, Giarin M, Saracco G et al. Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B. Gastroenterology 1993; 105: 845-50.
5. Brunetto RM, Stemler M, Schodel F et al. Identification of HBV variants which cannot produce precore derived HBeAg and may be responsible for severe hepatitis. Ital. J. Gastroenterol. 1989; 21: 151-4.
6. Okamoto H, Yotsumoto Y, Akahane T et al. Hepatitis B viruses with precore defects prevail in persistently infected hosts along with seroconversion to antiHBe. J. Virol. 1990; 64: 1298-303.
7. Tong S, Li J, Vitvitski L,Trepo C. Active hepatitis B virus replication in the presence of antiHBe is associated with viral variants containing an inactive pre-C region. Virology 1990; 176: 596-603.
8. Fattovich G, Brollo L, Alberto A et al Long-term follow-up of antiHBe positive chronic active hepatitis B. Hepatology 1988; 8: 1651-5.
9. Guptan RC, Thakur V, Sarin SK et al. Frequency and clinical profile of precore and surface hepatitis B mutants in Asian Indian patients with chronic liver disease. Am. J. Gastroenterol. 1996; 91: 1312-17.
10. Fang JWS, Tung FYT, Davis GL et al. Fibrosing cholestatic hepatitis in a transplant recipient with hepatitis B virus precore mutant. Gastroenterology 1993; 105: 901-4.
11. Yotsumoto S, Kojima M, Shoji I et al. Fulminant hepatitis related to transmission of hepatitis B variants with precore mutations between spouses. Hepatology 1992; 16: 31-5.
12. Raimondo G, Campo S, Smedile V et al. HBe antibody unrelated to 'e minus' hepatitis B virus variant infection in patients with chronic type D hepatitis. J. Hepatol. 1991; 13: S87-9.
13. Lok ASF, Hadziyannis SJ, Weller IVD et al. Contribution of low level HBV replication to continuing inflammatory activity in patients with anti HBe positive chronic hepatitis B virus infection. Gut 1984; 25: 1283-7.
14. Fattovich G, Farci P, Rugge M et al. A randomized controlled trial of lymphoblastoid interferon alfa in patients with chronic hepatitis B lacking HBeAg. Hepatology 1992; 15: 584-9.
15. Alberti A, Fattovich G. Interferon therapy for the antiHBe positive form of chronic hepatitis B. Antiviral Res. 1994; 24: 145-53.
16. Sarin SK, Guptan RC,ThakurV et al. Efficacy of low-dose recombinant alpha interferon therapy in HBV-related chronic liver disease patients in India: A randomized trial. J. Hepatol. 1996; 24: 391-6.
17. Banerjee K, Sharma G, Upadhyay S, Anand BS, Raju GS, Khandekar P. Detection of hepatitis B virus in blood samples negative for surface antigen by DNA probe hybridization assay. J. Bio. Sci. 1989; 14: 279-87.
18. Bukh J, Purcell RH, Miller RH. Importance of primer selection for the detection of hepatitis C virus RNA with polymerase chain reaction assay. Proc. Natl. Acad. Sci. USA 1991; 89: 187-91.
19. Knodell RG, Ishak KG, Black WL et al. Formulation of a numerical scoring system for assessing histological activity in a symptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
20. Brunetto MR, Overi F, Demartini A et al. Treatment with interferon of chronic hepatitis B associated with antibody to hepatitis Be antigen. J. Hepatol. 1991; 13 (Suppl. 1): 8-11.
21. Guptan RC, Malhotra S, Khandekar P, Sarin SK. Influence of low iron diet on the efficacy of interferon therapy in patients with chronic liver disease. Proceedings of 9th Biennial Scientific Meeting of the Asian Pacific Association for the Study of the Liver, Kuala Lumpur, Malaysia 1994; 161.
22. Guptan RC, Thakur V, Sarin SK. Iron and Liver: Current concepts in the pathogenesis and management of chronic liver diseases. J. Assoc. Physicians India 1996; 44: 198-201.
23. Brown JL, Carman WF, Thomas HC. The clinical significance of molecular variation within the hepatitis B virus genome. Hepatology 1992; 15: 144-8.
24. Lok ASF, Akara U, Green S. Mutations in the pre-core region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal. Proc. Natl Acad. Sci. USA 1994; 91: 4077-81.
25. Maruyama T, Schodel F, Iino S et al. Distinguishing between acute and symptomatic chronic hepatitis B virus infection. Gastroenterology 1994; 106: 1006-15.
26. Maruyama T, McLachlan A, Lino S et al. The serology of chronic hepatitis B infection revisited. J. Clin. Invest. 1993; 91: 2586-95.
27. Lok ASF, Akara U, Green S. Predictive value of precore hepatitis B virus mutation in spontaneous and interferon-induced hepatitis Be antigen clearance. Hepatology 1995; 21: 19-24.